Collectively, these findings suggest that hWJMSC-derived exosomes may mitigate HFD-induced metabolic dysfunction by reinforcing SIRT1-mediated metabolic processes, which consequently contributes to the protection against hepatic steatosis and insulin resistance. Here, SIRT1 is linked to fatty liver disease.